doi: 10.1093/ajcn/nqac049 171
While theres no specific research on C15:0 and GLP-1 medications, supporting your bodys anti-inflammatory response is a reasonable approach when dealing with oral tissue stress and systemic inflammation
A large retrospective cohort study published in JAMA Oncology evaluated more than 86,000 adults with obesity and found that individuals taking GLP-1 receptor agonists experienced a 17% lower overall risk of developing 13 out of 14 obesity-associated cancers compared with non-users, including a: 25% reduction in endometrial cancer
This study found an average of 4 mcg/d vitamin D, compared to the national average of 19 mcg/d from food and supplements, highlighting the significant need for Vitamin D-rich foods and supplementation for this population (44)
Endocrine Journal , 59(7), 529538
Our team will also conduct allergy assessments to identify any hypersensitivity to semaglutide GLP-1